The impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal Radiology Prostate Cancer Disease-Focused Panel survey analysis
Surasi DSS, Wang X, Bathala TK, Hwang H, Arora S, Westphalen AC, Chang SD, Turkbey B. The impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal Radiology Prostate Cancer Disease-Focused Panel survey analysis. Abdominal Radiology 2021, 46: 4362-4369. PMID: 33904992, PMCID: PMC8077193, DOI: 10.1007/s00261-021-03087-8.Peer-Reviewed Original ResearchMeSH KeywordsBiopsyCommunicable Disease ControlCOVID-19HumansImage-Guided BiopsyMagnetic Resonance ImagingMalePandemicsProstatic NeoplasmsRadiation OncologySARS-CoV-2ConceptsBowel preparationMedian numberProstate MRICoronavirus disease 2019 (COVID-19) pandemicCOVID-19Disease 2019 pandemicCOVID-19 pandemicHealth care systemComplete responseMedical oncologyProstate biopsyClinic schedulesProstate cancerMRI studiesLockdown periodCare systemCollateral damageRadiation oncologyClinical departmentsPanel survey analysisMRIBiopsyRadiology departmentOncologyDescriptive statistics